Why Piramal Enterprises ( NSE: PEL) rises 6% today? Buzzing Stock of the Day.
Piramal Enterprises Ltd NSE :PEL BSE :500302 Sector : Pharmaceuticals Stock today has seen a sharp up move and closed with 6% gains at 1808. PEL was top gaining...
Tag : Piramal Enterprises
Pharma Shares Decline, Dr Reddy’s Lab down by 1%
On Wednesday’s morning session, Pharma shares were trading lower with their sectoral index trading lower. Shares of Cadila Healthcare down by 0.47 per cent, Dr...
Piramal Shares Slip 3%, Plans to Sell Stake in Shriram Capital
In Morning trade on Tuesday, Piramal Enterprises’ shares declined over 3 per cent after it claimed it is planning to sell its entire holding of...
Piramal Enterprises to raise approx Rs.1,780 crore via rights issue
Piramal Enterprises, committee of directors have given approval to raising over Rs.1,780 crore via rights issue. In a BSE filing the company stated, “…pursuant to...
Piramal Enterprises acquires Digeplex
The Digeplex and associated brands has been acquired by Piramal Enterprises today, from Shreya Lifesciences, for an amount which is not disclosed. This acquisition will help...
Piramal Enterprises to raise Rs.7,000 crore
Ajay Piramal, group Chairman stated that, Piramal Enterprises will be raising approx Rs.7,000 crore in the next few months. As per Piramal, the company’s board...
Piramal Enterprises plans organic growth in pharma segment
Piramal Enterprises Ltd (PEL) has been planning to grow organically in pharmaceutical segment to move up the value chain and expand services like antibody drug...
Piramal Enterprises board approves to raise up to Rs 125 cr
Piramal Enterprises board has provided its approval for issuance of privately placed non-convertible debentures to raise up to Rs 125 crore. The company, however, did...
Piramal Enterprises aims to raise Rs 560 cr through NCDs
The board of Piramal Enterprises has approved the proposal to raise Rs 560 crore through issue of non-convertible debentures (NCDs). Piramal Enterprises has said in...
Piramal Enterprises has acquired Mallinckrodt LLC’s pain drug portfolio
Piramal Enterprises has concluded the acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt LLC. In January, the company had announced...